Опыт применения препарата Арника монтана С9 (БУАРОН) у детей после операции аденотомии

Abstract

The efficacy of Arnica Montana C9 (BOIRON) during the recovery period after adenotomy in 60 children aged 3 to 10 years was evaluated. All patients were randomly divided into 2 groups for further comparison. Each was composed of 30 patients. Patients of the control group were prescribed standard therapy: a sparing diet and regimen for 5 days, nasal vasoconstrictor drugs (nazivin 0.025% – 0.05%) at an age dosage of 5 days, inside-Nurofen at an age dosage (with pain in the throat and increased body temperature). Children of the main group received standard therapy + Arnica Montana C9 (BOIRON). Reception of the drug Arnica Montana C9 (Boiron) began from the second day after adenotomy with a dosage of 5 granules 4 times a day, from the 3rd to the 10th day-5 granules 3 times a day. Complaints and objective examination data were analyzed during 4 visits-observation by a doctor: on the second day after adenotomy (1st visit), on the 4th day (2nd visit) and on the 10th day after surgery (3rd visit), as well as 1 month after the end of therapy (4th visit). The study made it possible to draw a conclusion about the manifestation of positive changes in clinical indicators in children of the main group (reduction of pain intensity and intoxication, improvement of nasal breathing) on the 4th day after adenotomy relative to the control group. There was a significant decrease in the intake of painkillers in the group of children receiving Arnica Montana C9 (BOIRON). Given the result, we can talk about the possibility of reducing the drug load in patients. Thus, the inclusion Of Arnica Montana C9 (BOIRON) in the therapy of patients after adenotomy can lead to a significant reduction in the recovery period.